Joao Siffert joins Avanir as senior VP of R&D
This article was originally published in Scrip
Executive Summary
Avanir Pharmaceuticals has appointed Dr Joao Siffert to the newly created role of senior vice-president of research and development. Dr Siffert previously served as vice-president and chief medical officer at Ceregene, and also held senior positions at Avera Pharmaceuticals and Pfizer.
You may also be interested in...
Almirall launches Constella in six European markets
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira raises $35m in series B
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis ups public offering to $240m
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.